Rating History for Merrimack Pharmaceuticals (MACK) by TD Cowen

More Stocks Rated by TD Cowen | Latest Ratings for MACK
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/5/2016 N/A Downgrade
(Buy)		 N/A
(N/A)		 5.92
(15.13)		 155.57% Details